Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 69012T305 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
CVI Investments, Inc.
13G
|
9.9% |
8/19/2026
Event 8/12/2026
|
|
| CVI Investments, Inc. | 9.9% | ||
| Heights Capital Management, Inc. | 9.9% | ||
|
GMS Ventures & Investments
13D/A
Amendment 7
|
16.4% |
8/14/2026
Event 8/12/2026
|
|
| GMS Ventures & Investments | 16.4% | ||
| Sukhtian Ghiath M. | 16.4% | ||
|
GMS Ventures & Investments
13D/A
Amendment 6
|
22.9% |
6/1/2026
Event 5/28/2026
|
|
| GMS Ventures & Investments | 22.9% | ||
| Sukhtian Ghiath M. | 22.9% | ||
|
Intracoastal Capital LLC
13G
|
4.99% |
4/24/2026
Event 4/22/2026
|
|
| Mitchell P. Kopin | 4.99% | ||
| Daniel B. Asher | 4.99% | ||
| Intracoastal Capital LLC | 4.99% | ||
|
Sphera Funds Management Ltd.
13G/A
Amendment 2
|
4.7% |
2/5/2026
Event 12/31/2025
|
|
| Sphera Funds Management Ltd. | 4.7% | ||
| Sphera Global Healthcare GP Ltd. | 4.7% | ||
| Sphera Global Healthcare Management LP. | 4.7% | ||
|
Empery Asset Management, LP
13G/A
Amendment 1
|
4.99% |
10/21/2025
Event 9/30/2025
|
|
| Empery Asset Management, LP | 4.99% | ||
| Ryan M. Lane | 4.99% | ||
| Martin D. Hoe | 4.99% | ||
|
Tang Capital Management LLC
13G/A
Amendment 3
|
3.4% |
8/14/2025
Event 6/30/2025
|
|
| Tang Capital Management, LLC | 3.4% | ||
| Kevin Tang | 3.4% | ||
| Tang Capital Partners, LP | 3.4% | ||
| Tang Capital Partners International, LP | 0% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
|
Great Point Partners, LLC
13G/A
Amendment 4
|
4.99% |
8/14/2025
Event 6/30/2025
|
|
| Great Point Partners, LLC | 4.99% | ||
| Dr. Jeffrey R. Jay, M.D. | 4.99% | ||
| Ms. Lillian Nordahl | 4.99% | ||
|
Empery Asset Management, LP
13G
|
7.6% |
7/31/2025
Event 6/30/2025
|
|
| Empery Asset Management, LP | 7.6% | ||
| Ryan M. Lane | 7.6% | ||
| Martin D. Hoe | 7.6% | ||
|
GMS Ventures & Investments
13D/A
Amendment 5
|
50.3% |
5/28/2025
Event 5/27/2025
|
|
| GMS Ventures & Investments | 50.3% | ||
| Sukhtian Ghiath M. | 50.3% | ||
|
Tang Capital Management LLC
13G/A
Amendment 2
|
5.6% |
5/15/2025
Event 3/31/2025
|
|
| Tang Capital Management, LLC | 5.6% | ||
| Kevin Tang | 5.6% | ||
| Tang Capital Partners, LP | 4.9% | ||
| Tang Capital Partners International, LP | 0.3% | ||
| Tang Capital Partners III, Inc | 0.4% | ||
| Tang Capital Partners IV, Inc | 0% | ||
|
Great Point Partners, LLC
13G/A
Amendment 3
|
6.4% |
5/15/2025
Event 3/31/2025
|
|
| Great Point Partners, LLC | 6.4% | ||
| Dr. Jeffrey R. Jay, M.D. | 6.4% | ||
| Ms. Lillian Nordahl | 6.4% | ||
|
Sphera Funds Management Ltd.
13G/A
Amendment 1
|
7.5% |
4/10/2025
Event 4/10/2025
|
|
| Sphera Funds Management Ltd. | 7.5% | ||
| Sphera Global Healthcare GP Ltd. | 7.5% | ||
| Sphera Global Healthcare Management LP. | 7.5% | ||
|
GMS Ventures & Investments
13D/A
Amendment 4
|
41.6% |
3/12/2025
Event 3/11/2025
|
|
| GMS Ventures & Investments | 41.6% | ||
| Sukhtian Ghiath M. | 41.6% | ||
|
Sphera Funds Management Ltd.
13G
|
5.2% |
3/3/2025
Event 1/17/2025
|
|
| Sphera Funds Management Ltd. | 5.2% | ||
| Sphera Global Healthcare GP Ltd. | 5.2% | ||
| Sphera Global Healthcare Management LP | 5.2% | ||
|
Tang Capital Partners LP
13G/A
Amendment 1
|
6.4% |
2/14/2025
Event 12/31/2024
|
|
| Tang Capital Management, LLC | 6.4% | ||
| Kevin Tang | 6.4% | ||
| Tang Capital Partners, LP | 5.9% | ||
| Tang Capital Partners III, Inc | 0.5% | ||
| Tang Capital Partners IV, Inc | 0% | ||
|
Great Point Partners, LLC
13G/A
Amendment 2
|
8.2% |
2/14/2025
Event 12/31/2024
|
|
| Great Point Partners, LLC | 8.2% | ||
| Dr. Jeffrey R. Jay, M.D. | 8.2% | ||
| Ms. Lillian Nordahl | 8.2% | ||
|
GMS Ventures & Investments
13D/A
Amendment 3
|
38.6% |
1/22/2025
Event 1/17/2025
|
|
| GMS Ventures & Investments | 38.6% | ||
| Sukhtian Ghiath M. | 38.6% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 5 | 635 k | $364 k |
| 2026 Q2 | 77 | 20.5 M | $32.5 M |
| 2026 Q1 | 61 | 10.7 M | $2.21 M |
| 2025 Q4 | 63 | 6.83 M | $10.8 M |
| 2025 Q3 | 61 | 4.08 M | $4.33 M |
| 2025 Q2 | 70 | 6.00 M | $9.61 M |
| 2025 Q1 | 67 | 7.09 M | $8.65 M |
| 2024 Q4 | 66 | 4.55 M | $8.60 M |
| 2024 Q3 | 72 | 7.94 M | $42.4 M |
| 2024 Q2 | 68 | 8.06 M | $59.5 M |
| 2024 Q1 | 58 | 7.27 M | $86.6 M |
| 2023 Q3 | 1 | 34.2 k | $7.56 k |
| 2023 Q2 | 1 | 34.2 k | $59.5 k |
| 2023 Q1 | 1 | 34.2 k | $37.3 k |